Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00237874
Status:
COMPLETED
Last Update Posted:
2014-06-06
First Post:
2005-10-07
Brief Title:
Aripiprazole Treatment of Prodromal Patients
Sponsor:
Yale University
Organization:
Yale University
Study Overview
Official Title:
Aripiprazole Treatment of Prodromal Patients
Status:
COMPLETED
Status Verified Date:
2014-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We hypothesize that symptoms will improve in patients who meet diagnostic criteria for the schizophrenia prodrome when they are prescribed aripiprazole
Detailed Description:
This is an 8 week trial with extension for responders out to one year All patients receive active medication there is no placebo Patients must meet criteria for the schizophrenia prodrome according to the Structured Interview for Prodromal Syndromes Patients receive counseling as well All counseling and medication are free of charge
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None